Cargando…
Immunogenic Nanovesicle‐Tandem‐Augmented Chemoimmunotherapy via Efficient Cancer‐Homing Delivery and Optimized Ordinal‐Interval Regime
The strategy of combining immune checkpoint inhibitors (ICIs) with anthracycline is recommended by clinical guidelines for the standard‐of‐care treatment of triple‐negative breast cancer (TNBC). Nevertheless, several fundamental clinical principles are yet to be elucidated to achieve a great therape...
Autores principales: | Sun, Mengchi, Shi, Wen, Wu, Yuxia, He, Zhonggui, Sun, Jin, Cai, Shuang, Luo, Qiuhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811449/ https://www.ncbi.nlm.nih.gov/pubmed/36453573 http://dx.doi.org/10.1002/advs.202205247 |
Ejemplares similares
-
Recent advances in bacteriophage-based therapeutics: Insight into the post-antibiotic era
por: Ling, Hao, et al.
Publicado: (2022) -
Structurally defined tandem-responsive nanoassemblies composed of dipeptide-based photosensitive derivatives and hypoxia-activated camptothecin prodrugs against primary and metastatic breast tumors
por: Sun, Mengchi, et al.
Publicado: (2022) -
Dual-responsive nanosystem based on TGF-β blockade and immunogenic chemotherapy for effective chemoimmunotherapy
por: Huang, Xiaoxian, et al.
Publicado: (2022) -
Comparing interval estimates for small sample ordinal CFA models
por: Natesan, Prathiba
Publicado: (2015) -
Investigations on Cellular Uptake Mechanisms and Immunogenicity Profile of Novel Bio-Hybrid Nanovesicles
por: Ou, Yi-Hsuan, et al.
Publicado: (2022)